DrugPatentWatch Database Preview
Profile for Brazil Patent: 0211379
Join the DrugPatentWatch Referral Program Get access to a free drug patent landscape report or a free one-month subscription
US Patent Family Members and Approved Drugs for Brazil Patent: 0211379
US Patent Number | US Expiration Date | US Applicant | US Tradename | Generic Name |
---|---|---|---|---|
Start Trial | Jun 26, 2026 | Genzyme Corp | CERDELGA | eliglustat tartrate |
Start Trial | Apr 29, 2022 | Genzyme Corp | CERDELGA | eliglustat tartrate |
>US Patent Number | >US Expiration Date | >US Applicant | >US Tradename | >Generic Name |